137 related articles for article (PubMed ID: 9084851)
21. Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells.
Hettinga JV; Lemstra W; Meijer C; Dam WA; Uges DR; Konings AW; De Vries EG; Kampinga HH
Br J Cancer; 1997; 75(12):1735-43. PubMed ID: 9192975
[TBL] [Abstract][Full Text] [Related]
22. Synergistic interaction between cisplatin and gemcitabine in vitro.
Bergman AM; Ruiz van Haperen VW; Veerman G; Kuiper CM; Peters GJ
Clin Cancer Res; 1996 Mar; 2(3):521-30. PubMed ID: 9816199
[TBL] [Abstract][Full Text] [Related]
23. Docetaxel enhances the cytotoxicity of cisplatin to gastric cancer cells by modification of intracellular platinum metabolism.
Maeda S; Sugiura T; Saikawa Y; Kubota T; Otani Y; Kumai K; Kitajima M
Cancer Sci; 2004 Aug; 95(8):679-84. PubMed ID: 15298732
[TBL] [Abstract][Full Text] [Related]
24. Local hyperthermia enhances the effect of cis-diamminedichloro-platinum(II) on nonirradiated and preirradiated rat solid tumors.
van Bree C; Rietbroek RC; Schopman EM; Kipp JB; Bakker PJ
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):135-40. PubMed ID: 8823268
[TBL] [Abstract][Full Text] [Related]
25. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
Groen HJ; Sleijfer S; Meijer C; Kampinga HH; Konings AW; De Vries EG; Mulder NH
Br J Cancer; 1995 Dec; 72(6):1406-11. PubMed ID: 8519652
[TBL] [Abstract][Full Text] [Related]
26. Effect of tumor necrosis factor on human tumor cell lines sensitive and resistant to cytotoxic drugs, and its interaction with chemotherapeutic agents.
Soranzo C; Perego P; Zunino F
Anticancer Drugs; 1990 Dec; 1(2):157-63. PubMed ID: 2131048
[TBL] [Abstract][Full Text] [Related]
27. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
Kim R; Tanabe K; Inoue H; Toge T
Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of cytotoxicity of cisplatin in vitro by recombinant human tumor necrosis factor and/or recombinant human interferon-alpha, -beta and -gamma.
Kim CM; Hong WS; Lee JO; Kang TW; Kim YW; Song JK; Yun TK; Kim CY
Jpn J Cancer Res; 1989 Sep; 80(9):904-9. PubMed ID: 2513306
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
[TBL] [Abstract][Full Text] [Related]
30. Effect of heat-drug sequences on thermoenhancement and uptake of cis-DDP in human pharyngeal carcinoma.
Ohtsubo T; Saito H; Tanaka N; Noda I; Saito T; Kano E
Anticancer Res; 1996; 16(1):297-300. PubMed ID: 8615624
[TBL] [Abstract][Full Text] [Related]
31. Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines.
van de Vaart PJ; van der Vange N; Zoetmulder FA; van Goethem AR; van Tellingen O; ten Bokkel Huinink WW; Beijnen JH; Bartelink H; Begg AC
Eur J Cancer; 1998 Jan; 34(1):148-54. PubMed ID: 9624250
[TBL] [Abstract][Full Text] [Related]
32. Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin.
Los G; van Vugt MJ; Pinedo HM
Br J Cancer; 1994 Feb; 69(2):235-41. PubMed ID: 8297720
[TBL] [Abstract][Full Text] [Related]
33. Intraperitoneal chemotherapy for peritoneal metastases using sustained release formula of cisplatin-incorporated gelatin hydrogel granules.
Yamashita K; Tsunoda S; Gunji S; Murakami T; Suzuki T; Tabata Y; Sakai Y
Surg Today; 2019 Sep; 49(9):785-794. PubMed ID: 30847629
[TBL] [Abstract][Full Text] [Related]
34. Narrow line between benefit and harm: Additivity of hyperthermia to cisplatin cytotoxicity in different gastrointestinal cancer cells.
Cesna V; Sukovas A; Jasukaitiene A; Naginiene R; Barauskas G; Dambrauskas Z; Paskauskas S; Gulbinas A
World J Gastroenterol; 2018 Mar; 24(10):1072-1083. PubMed ID: 29563752
[TBL] [Abstract][Full Text] [Related]
35. Effect of hyperthermia on cis-diamminedichloroplatinum(II) (rhodamine 123)2[tetrachloroplatinum(II)] in a human squamous cell carcinoma line and a cis-diamminedichloroplatinum(II)-resistant subline.
Herman TS; Teicher BA; Cathcart KN; Kaufmann ME; Lee JB; Lee MH
Cancer Res; 1988 Sep; 48(18):5101-5. PubMed ID: 3409235
[TBL] [Abstract][Full Text] [Related]
36. Synergistic cytotoxicity of recombinant human TNF and various anti-cancer drugs.
Watanabe N; Niitsu Y; Yamauchi N; Ohtsuka Y; Sone H; Neda H; Maeda M; Urushizaki I
Immunopharmacol Immunotoxicol; 1988; 10(1):117-27. PubMed ID: 2452179
[TBL] [Abstract][Full Text] [Related]
37. Establishment of a cisplatin-resistant gastric carcinoma cell line OCUM-2M/DDP.
Nitta A; Chung YS; Nakata B; Yashiro M; Onoda N; Maeda K; Sawada T; Sowa M
Cancer Chemother Pharmacol; 1997; 40(1):94-7. PubMed ID: 9137537
[TBL] [Abstract][Full Text] [Related]
38. Role of heat treatment in childhood cancers: distinct resistance profiles of solid tumor cell lines towards combined thermochemotherapy.
Debes A; Willers R; Göbel U; Wessalowski R
Pediatr Blood Cancer; 2005 Oct; 45(5):663-9. PubMed ID: 15929134
[TBL] [Abstract][Full Text] [Related]
39. The synergistic and antagonistic effects of cytotoxic and biological agents on the in vitro antitumour effects of suramin.
Lopez Lopez R; van Rijswijk RE; Wagstaff J; Pinedo HM; Peters GJ
Eur J Cancer; 1994; 30A(10):1545-9. PubMed ID: 7833116
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy amplifies production of tumor necrosis factor.
Pogrebniak HW; Matthews W; Pass HI
Surgery; 1991 Aug; 110(2):231-7. PubMed ID: 1858032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
